
According to official statistics from the WHO in 2022, oncological diseases are now the cause of one in every six deaths worldwide. This has encouraged the international medical community to develop new cancer treatment methods and increase the effectiveness of the already existing ones. This is particularly important for patients...

Dendritic cell prostate cancer treatment represents a groundbreaking immunotherapy approach, recognized by the 2011 Nobel Prize in Physiology or Medicine, awarded to Ralph Steinman. This innovative method can be prescribed to men of all ages and at any stage of prostate cancer, serving as an effective addition to standard treatment....

Standard therapy for glioblastoma includes surgical removal of the tumor in combination with chemotherapy or radiation therapy. With standard treatment of glioblastoma, the average life expectancy after diagnosis is 15-17 months, and the 5-year survival rate does not exceed 5-10%. Supplementing the standard protocol with the dendritic cell...

Cervical cancer affects approximately 660,000 women worldwide each year, making it the fourth most common cancer among women globally. While early detection typically offers excellent cure rates, advanced cases require innovative treatment approaches. Dendritic cell therapy represents a promising personalized immunotherapy...

The treatment of liver cancer and liver cancer metastases is one of the most complex and challenging tasks, with this oncology type representing the 6th most common cancer worldwide with 866,136 new cases diagnosed in 2022. The diversity of primary cancers poses significant difficulties for both doctors and patients. Even more critical is liver...

Autism spectrum disorder (ASD) represents one of the most complex neurodevelopmental challenges facing families today. Affecting approximately 1 in 68 children in the United States, autism has become more common than childhood cancer, diabetes, and pediatric AIDS combined. While traditional treatments like behavioral therapy, speech...

Dementia affects 47 million people worldwide, with numbers expected to reach 131 million by 2050. While traditional treatments only manage symptoms, new treatment for dementia with stem cells offers new hope by targeting the root causes of brain damage. These remarkable cells can reduce harmful brain inflammation, clear toxic protein...

Lyme disease – a tick-borne infection caused by the bacterium Borrelia burgdorferi – is on the rise worldwide, with nearly 476,000 Americans diagnosed each year, though >30,000 cases are reported officially. Without prompt antibiotic treatment, the infection can progress through three stages, affecting the skin, joints, nervous system...